Hancock Jaffe Laboratories Inc EV/EBIT
Quel est le EV/EBIT de Hancock Jaffe Laboratories Inc?
Le EV/EBIT de Hancock Jaffe Laboratories Inc est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Health Care secteur sur NASDAQ par rapport à Hancock Jaffe Laboratories Inc
Que fait Hancock Jaffe Laboratories Inc?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Entreprises avec ev/ebit similaire à Hancock Jaffe Laboratories Inc
- Chesapeake a EV/EBIT de N/A
- Dynatronics a EV/EBIT de N/A
- North Peak Resources a EV/EBIT de N/A
- Angiodynamic Inc a EV/EBIT de N/A
- TGB Banquets and Hotels a EV/EBIT de N/A
- Enviroleach Technologies a EV/EBIT de N/A
- Hancock Jaffe Laboratories Inc a EV/EBIT de N/A
- Atyr Pharma Inc a EV/EBIT de N/A
- SCWorx Corp a EV/EBIT de N/A
- Solid Biosciences Inc a EV/EBIT de N/A
- Meteorite Capital a EV/EBIT de N/A
- Simran Farms a EV/EBIT de N/A
- Comscore a EV/EBIT de N/A